Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,182 | 116,328 | 69,418 | 112,616 | 143,789 |
| Marketable Securities | 182,673 | 181,735 | 271,924 | 254,009 | 273,531 |
| Receivables | 26,682 | 23,348 | 18,430 | 15,254 | 12,378 |
| Inventories | 4,737 | 5,583 | 5,248 | 5,536 | 6,003 |
| TOTAL | $301,096 | $340,014 | $373,477 | $401,972 | $443,745 |
| Non-Current Assets | |||||
| PPE Net | 2,760 | 2,709 | 2,662 | 2,991 | 3,296 |
| Intangibles | 4,800 | 5,169 | 5,538 | 5,907 | 6,277 |
| Other Non-Current Assets | 6,304 | 3,148 | 2,829 | 2,844 | 2,997 |
| TOTAL | $13,864 | $11,026 | $11,029 | $11,742 | $12,570 |
| Total Assets | $314,960 | $351,040 | $384,506 | $413,714 | $456,315 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,333 | 2,996 | 8,786 | 2,962 | 3,588 |
| Accrued Expenses | 45,881 | 43,093 | 40,244 | 33,181 | 37,325 |
| TOTAL | $49,214 | $46,089 | $49,030 | $36,143 | $40,913 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,026 | 782 | 191 | 245 | 262 |
| TOTAL | $1,026 | $782 | $191 | $245 | $262 |
| Total Liabilities | $50,240 | $46,871 | $49,221 | $36,388 | $41,175 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 125,007 | 124,826 | 124,702 | 124,206 | 122,400 |
| Common Shares | 12 | 12 | 12 | 12 | 12 |
| Retained earnings | -1,341,233 | -1,277,967 | -1,223,671 | -1,154,801 | -1,089,553 |
| Other shareholders' equity | -500 | -699 | -399 | -73 | -97 |
| TOTAL | $264,720 | $304,169 | $335,285 | $377,326 | $415,140 |
| Total Liabilities And Equity | $314,960 | $351,040 | $384,506 | $413,714 | $456,315 |